inhibitors Acarbose, Miglitol, VogliboseThiazolidinediones (TZD) amaryl city-hotel Rivoglitazone†, Rosiglitazone, Troglitazone‡Meglitinides Nateglinide, Repaglinide, MitiglinideDipeptidyl peptidase-4 (DPP-4) inhibitors Alogliptin,† Saxagliptin,† Sitagliptin, VildagliptinGlucagon-like peptide-1 analog.

carboxamideIdentifiersCAS number 93479-97-1ATC code amaryl city-hotel 3476DrugBank APRD00381Chemical dataFormula C24H34N4O5SMol. mass 490.617 g/molPharmacokinetic dataBioavailability ?Protein binding >99.5%Metabolism ?Half life ?Excretion ?Therapeutic considerationsPregnancy cat. ?Legal statusRoutes ?Glimepiride is amaryl city-hotel medium-to-long acting sulfonylurea anti-diabetic drug. It is marketed as Amaryl by Sanofi-Aventis. Glimepiride is the first third-generation sulfonylurea, and is very potent.Contents [hide]1 Indications2 Adverse effects3 Contraindications4 Interactions5 Pharmacology6 Mechanism of action[edit] amaryl city-hotel 2 amaryl city-hotel (NIDDM).[edit] Adverse effectsMain amaryl city-hotel SulfonylureaGI disturbance, rarely thrombopenia , leucopenia, haemolytic anaemia, occasionally allergic. In the initial weeks of treatment, the risk of hypoglycemia may be increased.[edit] amaryl city-hotel to glimepiride or other sulfonylureas. -Pregnancy[edit].

the hypoglycemic action of glimepride. Thiazides, other diuretic, phothiazides, thyroid products, oral.